The latest quarterly R&D expense is $20.09 Million with a QoQ Growth of -9.48%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q3 FY2026 (2026-07-31).
Reported quarterly R&D expense; no daily interpolation. Q3 FY2026 (2026-07-31): $20.09M.
$20.09M
$20.09 Million
Q3 FY2026 · 2026-07-31
-9.48%
vs. $22.20M prior quarter
19
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q3 FY2026Period end 2026-07-31 | $20.09M | -9.48% | -11.01% |
| Q2 FY2026Period end 2026-04-30 | $22.20M | -0.27% | +9.83% |
| Q1 FY2026Period end 2026-01-31 | $22.25M | -29.84% | +11.42% |
| Q4 FY2025Period end 2025-10-31 | $31.72M | +40.52% | +181.40% |
| Q3 FY2025Period end 2025-07-31 | $22.57M | +11.71% | +95.47% |
| Q2 FY2025Period end 2025-04-30 | $20.21M | +1.18% | +105.06% |
| Q1 FY2025Period end 2025-01-31 | $19.97M | +77.18% | +254.27% |
| Q4 FY2024Period end 2024-10-31 | $11.27M | -2.39% | +98.78% |
| Q3 FY2024Period end 2024-07-31 | $11.55M | +17.19% | +196.05% |
| Q2 FY2024Period end 2024-04-30 | $9.86M | +74.80% | +206.53% |
| Q1 FY2024Period end 2024-01-31 | $5.64M | -0.58% | +53.58% |
| Q4 FY2023Period end 2023-10-31 | $5.67M | +45.37% | +11.66% |
| Q3 FY2023Period end 2023-07-31 | $3.90M | +21.34% | -11.22% |
| Q2 FY2023Period end 2023-04-30 | $3.21M | -12.42% | -6.19% |
| Q1 FY2023Period end 2023-01-31 | $3.67M | -27.72% | N/A |
| Q4 FY2022Period end 2022-10-31 | $5.08M | +15.59% | N/A |
| Q3 FY2022Period end 2022-07-31 | $4.39M | +28.22% | N/A |
| Q2 FY2022Period end 2022-04-30 | $3.43M | N/A | N/A |
| Q1 FY2022Period end 2021-12-31 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
